Aprepitant and Swallowing pain or burning - a phase IV clinical study of FDA data

Summary:

Swallowing pain or burning is reported as a side effect among people who take Aprepitant (aprepitant), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ondansetron, and have Nausea and vomiting.

The phase IV clinical study analyzes which people have Swallowing pain or burning when taking Aprepitant. It is created by eHealthMe based on reports of 6,989 people who have side effects when taking Aprepitant from the FDA, and is updated regularly.

What is Aprepitant?

Aprepitant has active ingredients of aprepitant. eHealthMe is studying from 6,992 Aprepitant users. Check the latest studies of Aprepitant.

What is Swallowing pain or burning?

Swallowing pain or burning is found to be associated with 777 drugs and 1,136 conditions by eHealthMe. Check the latest studies of Swallowing pain or burning.

On Aug, 05, 2026

6,989 people reported to have side effects when taking Aprepitant.
Among them, 11 people (0.16%) have Swallowing pain or burning.

Could Aprepitant cause Swallowing pain or burning?

Among these 11 people:

How long have people been on Aprepitant when they have Swallowing pain or burning? *

What is the gender of people who have Swallowing pain or burning when taking Aprepitant? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Swallowing pain or burning when taking Aprepitant? *

What are other drugs people take besides Aprepitant? *

Ondansetron: 2 people, 18.18%
Prochlorperazine Edisylate: 1 person, 9.09%
Neulasta: 1 person, 9.09%
Lorazepam: 1 person, 9.09%
Fluorouracil: 1 person, 9.09%
Cisplatin: 1 person, 9.09%

What are other side effects people have besides Swallowing pain or burning? *

Swallowing Difficulty: 9 people, 81.82%
Fever: 8 people, 72.73%
Mucosal Inflammation (infection of mucous membrane): 7 people, 63.64%
Fungal Infection: 4 people, 36.36%
Diarrhea: 3 people, 27.27%
Cough: 2 people, 18.18%
Dyspnea (difficult or laboured breathing): 2 people, 18.18%
Mucosal Infection (infection of mucous membrane): 2 people, 18.18%
Hyperglycemia (high blood sugar): 2 people, 18.18%
Nausea (feeling of having an urge to vomit): 2 people, 18.18%

What are the existing conditions these people have? *

Nausea And Vomiting: 6 people, 54.55%
Inflammation: 5 people, 45.45%
Hyperchlorhydria (gastric acid levels are higher in stomach): 5 people, 45.45%
Histamine Level Increased: 5 people, 45.45%
Haematological Malignancy (cancer that affect blood, bone marrow, and lymph nodes): 5 people, 45.45%
Metastatic Gastric Cancer (cancer types can spread to the stomach from other place): 1 person, 9.09%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 1 person, 9.09%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Aprepitant and have Swallowing pain or burning?

- Check whether Swallowing pain or burning is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aprepitant:

Aprepitant (6,992 reports)

Browse all side effects of Aprepitant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing pain or burning:

Swallowing pain or burning (777 drugs)

Browse all the conditions that are associated with Swallowing pain or burning:

Swallowing pain or burning (1,136 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aprepitant (the active ingredients of Aprepitant) and Aprepitant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.